Active and Sham Light Intervention

Dosage & preparation

Preparation

Risks & contraindications

Comparisons

Highlighted claims

• Participants complete 30-minute morning light sessions on waking for 14 consecutive days. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
• Both trial groups wear the same DAYVIA SUNACTIV 2 light therapy glasses. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
• Active BLT is intended to target melanopsin cells, while sham BLT uses a yellowish low-intensity spectrum to avoid melanopsin activation. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
• The light therapy device is contraindicated only in specific ophthalmic conditions including retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, and glaucoma. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
• Prior safety data showed similar side-effect rates between active and sham BLT and no serious adverse events. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial